This message contains images. If you don't see images, click here to view.
Click here to advertise in this news brief.

  Mobile version   RSS   Subscribe   Unsubscribe
Home   Join   Fellows' Corner June. 1, 2011
 
 
 

Bone metastases of thyroid tumors should be treated with bisphosphonates
Clinical Thyroidology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Bisphosphonates are increasingly being used to delay the growth of bone metastases in a number of cancers, such as in malignant tumors of the lung, breast, prostate, and kidney and in multiple myeloma. They have also been reported to be of value in metastatic thyroid cancer, but most reports include only a small number of cases. Bisphosphonates inhibit osteoclastic bone resorption, and in the cancers mentioned above bisphosphonates are able to decrease the release of markers of bone resorption such as pyridinoline-cross-linked carboxy terminal telopeptide. More

Hashimoto's thyroiditis affects symptom load and quality of life unrelated to hypothyroidism: A prospective case - control study in women undergoing thyroidectomy for benign goiter
Thyroid    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Hashimoto's thyroiditis (HT) is a common disease, and is the most prevalent cause of hypothyroidism. Symptoms and diseases associated with HT are considered to be caused by hypothyroidism. We hypothesized that higher antithyroperoxidase (anti-TPO) antibody levels would be associated with an increased symptom load and a decreased quality of life in a female euthyroid patient collective. More



Imaging in thyroid cancer patients with spread of the cancer outside of the neck
Clinical Thyroidology for Patients    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The vast majority of patients diagnosed with thyroid cancer do very well. Most are cured of their cancer through a combination of surgery and radioactive iodine, which is taken up by the cancer to destroy it. While overall death from thyroid cancer is rare, the prognosis of thyroid cancer patients with spread of the cancer outside of the neck is less favorable. This is especially true for patients over the age of 45 or if the cancer does not take up radioactive iodine. FDG-PET scans use a small amount of radioactive glucose (FDG) to identify cancer and have been used to predict prognosis in other cancers. This study examined whether FDG-PET scans can be used as a prognostic factor in thyroid cancer patients with spread of the cancer outside of the neck. More

Does placental iodine storage compensate for low maternal iodine intake?
Clinical Thyroidology    Share    Share on FacebookTwitterShare on LinkedinE-mail article
The authors' objective is to compare the iodine content of placentas from women giving birth at term in Ireland and Iran, areas with a median urinary iodine (UI) of 79 µg/L and 206 µg/L, respectively. Controversy exists about the role of the placenta in transferring to the fetus iodine ingested by the mother. Although there is evidence of subclinical hypothyroidism or hypothyroxinemia in children born to women with borderline to low dietary iodine intake as assessed by urinary iodine excretion, the majority of mothers and infants show no ill effects from moderate iodine deficiency. More

Radiation safety in the treatment of patients with thyroid diseases by radioiodine 131-I: Practice recommendations of the American Thyroid Association
Thyroid    Share    Share on FacebookTwitterShare on LinkedinE-mail article
Radiation safety is an essential component in the treatment of patients with thyroid diseases by 131-I. The American Thyroid Association created a task force to develop recommendations that would inform medical professionals about attainment of radiation safety for patients, family members, and the public. The task force was constituted so as to obtain advice, experience, and methods from relevant medical specialties and disciplines. More
 
 
ATA Thyroid Weekly News Briefs
ATA does not develop, exert any editorial or other control, or guarantee the accuracy, completeness, efficacy, or timeliness, of the materials, information, advertising or promotional activities ("Content") in this publication. Inclusion of Content in this publication does not constitute or imply endorsement, agreement, recommendation, or favoring by ATA of such information or the entities mentioned or promoted herein. Use of any Content appearing or referenced in this publication or obtained from advertisers is voluntary, and reliance on it should only be undertaken after an independent review by qualified experts. ATA is not responsible for, and expressly disclaims all liability for, damages of any kind arising out of use of, reference to, reliance on, or performance pursuant to such Content.

Colby Horton, Vice President of Publishing, 469.420.2601   Download media kit
Julie Bernhard, Content Editor, 469.420.2647   Contribute news
This edition of the ATA Weekly News Brief was sent to ##Email##. To unsubscribe, click here. Did someone forward this edition to you? Subscribe here -- it's free!
Recent issues
May 25, 2011
May 18, 2011
May 11, 2011
May 4, 2011



7701 Las Colinas Ridge, Ste. 800, Irving, TX 75063